Cargando…
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts
INTRODUCTION: Hidradenitis suppurativa (HS) patients may be at increased risk of COVID-19 infection and complications from their medications and comorbidities. There is a lack of expert consensus on recommendations for the COVID-19 vaccine for HS patients. Herein, we aim to provide expert-driven con...
Autores principales: | Rick, Jonathan W., De, Devea R., Shih, Terri, Alavi, Afsaneh, Kirby, Joslyn S., Naik, Haley B., Frew, John W., Sayed, Christopher J., Hsiao, Jennifer L., Shi, Vivian Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274824/ https://www.ncbi.nlm.nih.gov/pubmed/35979524 http://dx.doi.org/10.1159/000521268 |
Ejemplares similares
-
Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study
por: Masson, Rahul, et al.
Publicado: (2023) -
COVID-19 Infection in Hidradenitis Suppurativa Patients: A Retrospective Study
por: De, Devea R., et al.
Publicado: (2023) -
Optimizing hidradenitis suppurativa clinic visits: Patient perspectives
por: Shih, Terri, et al.
Publicado: (2022) -
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022) -
Integrating primary palliative care into hidradenitis suppurativa management
por: Shih, Terri, et al.
Publicado: (2022)